Italia - italiano - Ministero della Salute

deca laboratorio chimico srl -

Italia - italiano - Ministero della Salute

deca laboratorio chimico srl -

Italia - italiano - Ministero della Salute

deca laboratorio chimico srl -

Italia - italiano - Ministero della Salute

deca laboratorio chimico srl -

Italia - italiano - Ministero della Salute

deca laboratorio chimico srl -

Unione Europea - italiano - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - agenti antineoplastici - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

bristol-myers squibb sa - idecabtagenum vicleucelum 260-500 x 10⁶ car-positive viable t zellen - von 260 bis 500 × 10e6 car-positiven lebensfähigen t-zellen - beutel 260 bis 500 × 10e6 car-positiven lebensfähigen t-zellen: idecabtagenum vicleucelum 260-500 x 10⁶ car-positive viable t zellen, natrii chloridum, natrii gluconas, natrii acetas trihydricus, kalii chloridum, magnesii chloridum 4.5-hydricum, aqua ad iniectabile, cryostor cs10, ad praeparationem pro. - abecma ist für die behandlung von erwachsenen patienten mit rezidiviertem und refraktärem multiplem myelom indiziert, die zuvor mindestens drei therapien erhalten haben, inklusive einem immunmodulatorischen wirkstoff, einem proteasom-inhibitor und einem anti-cd38-antikörper, und welche eine progredienz zur letzten therapie gezeigt haben. - trapianto: gentherapieprodukt

Italia - italiano - Ministero della Salute

sharda cropchem limited - deltametrina; - concentrato emulsionabile - 2.81 g i valori indicati sono per 100 g di prodotto. - diserbante - diserbante - (n) pericoloso per l''ambiente (xn) nocivo

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

aspen pharma trading limited - nandrolone - nandrolone

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

aspen pharma schweiz gmbh - nandroloni decanoas - soluzione iniettabile (i. m.) - nandroloni decanoas 50 mg, conserv.: alcohol benzylicus 0.1 ml, arachidis oleum raffinatum q.s. ad solutionem pro 1 ml. - provata l'osteoporosi nelle donne in postmenopausa - synthetika